04/01/2025 5:08 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:02 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:02 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:04 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:06 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:07 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:08 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 4:00 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2025 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/17/2025 5:35 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:36 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/17/2025 5:37 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:38 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:21 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:51 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
03/03/2025 7:42 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:27 PM | ARMISTICE CAPITAL, LLC (Filed by) BioXcel Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025 7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 4:28 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/20/2025 11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025 7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2025 7:03 AM | BioXcel Therapeutics (Issuer) Patni Rajiv (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/16/2025 7:04 AM | BioXcel Therapeutics (Issuer) Patni Rajiv (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:00 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:01 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:03 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/08/2025 6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/30/2024 3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
12/18/2024 7:19 PM | BioXcel Therapeutics (Subject) Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024 4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024 4:20 PM | BioXcel Therapeutics (Subject) Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
12/17/2024 5:10 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:03 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:04 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:06 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:08 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:21 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 2:33 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024 2:23 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad) We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America.
Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking.
And he believes Trump could soon release this frozen asset to the public.
 But something even more spectacular is bound to happen. And those who know what to expect could make |
12/16/2024 2:00 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 1:10 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 3:05 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/25/2024 3:06 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024 3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024 8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 8:53 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:54 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:54 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:33 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:40 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:17 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2024 6:17 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024 6:18 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:19 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:20 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:21 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:21 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:23 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 4:42 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:26 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:16 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 2:48 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 1:58 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 12:23 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 9:47 AM | BioXcel Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024 3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2024 3:41 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 8:22 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4/A | |
06/18/2024 8:24 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:25 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:25 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:26 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:26 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:27 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 2:13 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 1:34 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 1:09 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 12:46 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse (Ad) Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement.
When the dollar collapses, your savings could disappear overnight.
With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar. Go Here to Learn What's Happening and How to Prepare >> |
06/17/2024 12:04 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 12:21 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 6:00 PM | BioXcel Therapeutics (Issuer) Bray June (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:00 PM | BioXcel Therapeutics (Issuer) MILLER MICHAEL PATRICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:01 PM | BioXcel Therapeutics (Issuer) MUELLER PETER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:01 PM | BioXcel Therapeutics (Issuer) Laumas Sandeep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:02 PM | BioXcel Therapeutics (Issuer) Votruba Michal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:29 PM | BioXcel LLC (Filed by) BioXcel Therapeutics (Subject)
| Form SC 13D/A | |
06/06/2024 7:35 PM | BioXcel Holdings, Inc. (Reporting) BioXcel LLC (Reporting) BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |